Clinical Trial Update: Evaluation of Iron Supplementation During Darbepoetin Alfa Treatment in Prophylaxis of Severe Anaemia Chemo-Induced [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating iron supplementation during darbepoetin alfa treatment to prevent chemotherapy-induced severe anemia has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Cancer

Drugs mentioned

• Iron supplementation (Iron)
• darbepoetin alfa (darbepoetin alfa)

Snippet

Sponsor: Institut Claudius Regaud | Conditions: Neoplasms, Anemia | Phase 2 | Status: TERMINATED